- IBIO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
iBio (IBIO) CORRESPCorrespondence with SEC
Filed: 24 Oct 19, 12:00am
IBIO, INC.
600 Madison Avenue, Suite 1601
New York, NY 10022-1737
VIA EDGAR
October 24, 2019
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
RE: | iBio, Inc. | |
Registration Statement on Form S-1 (File No. 333-233504) | ||
Acceleration Request |
Ladies and Gentlemen:
Pursuant to Rule 461, iBio, Inc. (the “Company”) hereby requests the Securities and Exchange Commission to accelerate the effective date of the above-referenced Registration Statement and declare the Registration Statement effective as of 4:15 p.m. Eastern Time on Thursday, October 24, 2019, or as soon thereafter as practicable.
Sincerely, | ||
IBIO, INC. | ||
By: | /s/ Robert B. Kay | |
Name: Robert B. Kay | ||
Title: Executive Chairman and Chief Executive Officer |